Skip to content

Comparing Stationary and Mobile Ergospirometry

Comparing the Results of a Stationary and a Mobile Ergospirometry System - a Randomized Crossover Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06194110
Acronym
QK5_2days
Enrollment
20
Registered
2024-01-08
Start date
2023-09-30
Completion date
2024-07-30
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athletes

Keywords

endurance trained, ergospirometry, Vo2peak

Brief summary

The goal of this randomized crossover trial is to compare the results of a stationary and a mobile ergospirometry system in 20 healthy endurance trained participants. The main question it aims to answer is to investigate the differences in VO2-measurements between the mobile K5 and the stationary Quark ergospirometry system. Participants will do a maximal ramp test followed by a sub maximal step test with 6 stages on two different days.

Detailed description

20 endurance trained men and/or women will be recruited. A screening will be done before starting with the test protocol on the treadmill to ensure the suitability of the participants. The test protocol includes two parts. The first part is a maximal ramp test (+0.6km/h each minute until exhaustion). The second part includes a step test with 6 sub maximal stages - each lasting 5 minutes - at 50%, 55%, 60%, 70%, 75% and 80% of the maximal velocity achieved in the first part. There will be a short break between the ramp and the step test. The stationary and the mobile system are tested on 2 separate days with a break of 1-3 days in between. On the second day, procedure will be exactly the same for the participants.

Interventions

DIAGNOSTIC_TESTErgometric test

Ramp test followed by a step test, both with ergospirometry

Sponsors

Swiss Paraplegic Research, Nottwil
Lead SponsorNETWORK

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* endurance trained (minimum two times endurance training per week) * healthy as assessed by the physical-activity-readiness-questionnaire (PAR-Q) * adequately informed and consent confirmed per signature

Exclusion criteria

* Pregnancy based on anamnesis * acute illness, injury, infection, etc., which would impact the measurements

Design outcomes

Primary

MeasureTime frameDescription
VO2 peakduring the last 30 seconds of the ramp testMaximal oxygen consumption (VO2) peak values during the ramp test

Secondary

MeasureTime frameDescription
VO2during the last 2 minutes of the step testoxygen consumption (VO2) values during step test in steady state
VCO2during the last 2 minutes of the step testcarbon dioxide production (VCO2) values during step test in steady state
Ventilationduring the last 2 minutes of the step testVentilation during step test in steady state
breathing frequencyduring the last 2 minutes of the step testbreathing frequency values during step test in steady state

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026